
Nicole Erin Kinsey White
Examiner (ID: 18489, Phone: (571)272-9943 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1130 |
| Issued Applications | 560 |
| Pending Applications | 136 |
| Abandoned Applications | 472 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13444737
[patent_doc_number] => 20180273911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => ATTENUATED VIRUS MUTATED AT SITES OF EVOLUTIONARILY CONSERVED RNA STRUCTURE
[patent_app_type] => utility
[patent_app_number] => 15/764691
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764691
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/764691 | Attenuated virus mutated at sites of evolutionarily conserved RNA structure | Sep 28, 2016 | Issued |
Array
(
[id] => 18201210
[patent_doc_number] => 11583581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Methods of treating a retroviral infection
[patent_app_type] => utility
[patent_app_number] => 15/760424
[patent_app_country] => US
[patent_app_date] => 2016-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 3831
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760424
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760424 | Methods of treating a retroviral infection | Sep 20, 2016 | Issued |
Array
(
[id] => 17323777
[patent_doc_number] => 11214773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Antibacterial and protective bacteriophage formulations and methods for making and using them
[patent_app_type] => utility
[patent_app_number] => 15/762908
[patent_app_country] => US
[patent_app_date] => 2016-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 24
[patent_no_of_words] => 26243
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15762908
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/762908 | Antibacterial and protective bacteriophage formulations and methods for making and using them | Sep 19, 2016 | Issued |
Array
(
[id] => 11621088
[patent_doc_number] => 20170131275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'METHODS AND SYSTEMS FOR DETECTION OF MICROORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 15/263619
[patent_app_country] => US
[patent_app_date] => 2016-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 23336
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15263619
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/263619 | METHODS AND SYSTEMS FOR DETECTION OF MICROORGANISMS | Sep 12, 2016 | Abandoned |
Array
(
[id] => 11492845
[patent_doc_number] => 20170067030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'ATTENUATED VIRUSES USEFUL FOR VACCINES'
[patent_app_type] => utility
[patent_app_number] => 15/258584
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 57097
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258584
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/258584 | Methods of making modified viral genomes | Sep 6, 2016 | Issued |
Array
(
[id] => 12979726
[patent_doc_number] => 20170342113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => RECOMBINANT H7 HEMAGGLUTININ AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/255567
[patent_app_country] => US
[patent_app_date] => 2016-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255567
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/255567 | RECOMBINANT H7 HEMAGGLUTININ AND USE THEREOF | Sep 1, 2016 | Abandoned |
Array
(
[id] => 13383711
[patent_doc_number] => 20180243397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => NOROVIRUS VACCINE
[patent_app_type] => utility
[patent_app_number] => 15/754807
[patent_app_country] => US
[patent_app_date] => 2016-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10257
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15754807
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/754807 | NOROVIRUS VACCINE | Aug 25, 2016 | Abandoned |
Array
(
[id] => 11335655
[patent_doc_number] => 20160361409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'H5 PROTEINS OF H5N1 INFLUENZA VIRUS FOR USE AS A MEDICAMENT'
[patent_app_type] => utility
[patent_app_number] => 15/246959
[patent_app_country] => US
[patent_app_date] => 2016-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33838
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15246959
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/246959 | H5 PROTEINS OF H5N1 INFLUENZA VIRUS FOR USE AS A MEDICAMENT | Aug 24, 2016 | Abandoned |
Array
(
[id] => 11728075
[patent_doc_number] => 20170189518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'NUCLEIC ACID MOLECULES ENCODING FERRITIN-HEMAGGLUTININ FUSION PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 15/244321
[patent_app_country] => US
[patent_app_date] => 2016-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 91
[patent_no_of_words] => 40256
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15244321
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/244321 | Nucleic acid molecules encoding ferritin-hemagglutinin fusion proteins | Aug 22, 2016 | Issued |
Array
(
[id] => 13887775
[patent_doc_number] => 10196428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-05
[patent_title] => Modification of cupredoxin derived peptides
[patent_app_type] => utility
[patent_app_number] => 15/232197
[patent_app_country] => US
[patent_app_date] => 2016-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 97
[patent_no_of_words] => 37956
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15232197
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/232197 | Modification of cupredoxin derived peptides | Aug 8, 2016 | Issued |
Array
(
[id] => 11492862
[patent_doc_number] => 20170067044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE DETECTION OF TARGET MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 15/221120
[patent_app_country] => US
[patent_app_date] => 2016-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12574
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15221120
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/221120 | METHODS AND COMPOSITIONS FOR THE DETECTION OF TARGET MOLECULES | Jul 26, 2016 | Abandoned |
Array
(
[id] => 13871363
[patent_doc_number] => 20190032022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => NEW BACTERIOPHAGE STRAINS AGAINST PROTEUS MIRABILIS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/742127
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15742127
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/742127 | Bacteriophage strains against proteus mirabilis and use thereof | Jul 6, 2016 | Issued |
Array
(
[id] => 11337000
[patent_doc_number] => 20160362755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'Paramyxovirus and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 15/180544
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19108
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15180544
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/180544 | Cedar virus and methods of use | Jun 12, 2016 | Issued |
Array
(
[id] => 11310266
[patent_doc_number] => 20160346377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'VACCINE COMPOSITIONS AGAINST PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME AND PORCINE CIRCOVIRUS ASSOCIATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/167911
[patent_app_country] => US
[patent_app_date] => 2016-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7509
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15167911
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/167911 | Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases | May 26, 2016 | Issued |
Array
(
[id] => 11290494
[patent_doc_number] => 20160340427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'Molecular constructs for treating infectious diseases'
[patent_app_type] => utility
[patent_app_number] => 15/159863
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11607
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15159863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/159863 | Molecular constructs for treating infectious diseases | May 19, 2016 | Abandoned |
Array
(
[id] => 11040168
[patent_doc_number] => 20160237123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/146511
[patent_app_country] => US
[patent_app_date] => 2016-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 27016
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15146511
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/146511 | Compositions and methods comprising hydrocarbon-stapled polypeptides | May 3, 2016 | Issued |
Array
(
[id] => 13504765
[patent_doc_number] => 20180303925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => Nucleoside-Modified RNA For Inducing an Adaptive Immune Response
[patent_app_type] => utility
[patent_app_number] => 15/569546
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569546
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569546 | Nucleoside-Modified RNA For Inducing an Adaptive Immune Response | Apr 26, 2016 | Abandoned |
Array
(
[id] => 13519495
[patent_doc_number] => 20180311290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => MODULATION OF AAV VECTOR TRANSGENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 15/567847
[patent_app_country] => US
[patent_app_date] => 2016-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15567847
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/567847 | Modulation of AAV vector transgene expression | Apr 19, 2016 | Issued |
Array
(
[id] => 11323849
[patent_doc_number] => 20160354461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'SIV AND HIV VACCINATION USING RHCMV- AND HCMV-BASED VACCINE VECTORS'
[patent_app_type] => utility
[patent_app_number] => 15/092024
[patent_app_country] => US
[patent_app_date] => 2016-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28130
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092024
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/092024 | SIV AND HIV VACCINATION USING RHCMV- AND HCMV-BASED VACCINE VECTORS | Apr 5, 2016 | Abandoned |
Array
(
[id] => 11443483
[patent_doc_number] => 20170044502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'METHODS OF MAKING RECOMBINANT PHAGE, COMPOSITIONS AND ARTICLES OF MANUFACTURE OF SAME FOR BACTERIAL DETECTION'
[patent_app_type] => utility
[patent_app_number] => 15/087151
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 38000
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15087151
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/087151 | Recombinant phage for listeria detection | Mar 30, 2016 | Issued |